The therapeutic index (TI; also referred to as therapeutic ratio) is a quantitative measurement of the relative safety of a drug with regard to risk of overdose. It is a comparison of the amount of a therapeutic agent that causes toxicity to the amount that causes the therapeutic effect. The related terms therapeutic window or safety window refer to a range of doses optimized between efficacy and toxicity, achieving the greatest therapeutic benefit without resulting in unacceptable side-effects or toxicity. Classically, for clinical indications of an approved drug, TI refers to the ratio of the dose of the drug that causes adverse effects at an incidence/severity not compatible with the targeted indication (e.g. toxic dose in 50% of subjects, TD50) to the dose that leads to the desired pharmacological effect (e.g. efficacious dose in 50% of subjects, ED50). In contrast, in a drug development setting TI is calculated based on plasma exposure levels. In the early days of pharmaceutical toxicology, TI was frequently determined in animals as lethal dose of a drug for 50% of the population (LD50) divided by the minimum effective dose for 50% of the population (ED50). In modern settings, more sophisticated toxicity endpoints are used. For many drugs, severe toxicities in humans occur at sublethal doses, which limit their maximum dose. A higher safety-based therapeutic index is preferable instead of a lower one; an individual would have to take a much higher dose of a drug to reach the lethal threshold than the dose taken to induce the therapeutic effect of the drug. However, a lower efficacy-based therapeutic index is preferable instead of a higher one; an individual would have to take a higher dose of a drug to reach the toxic threshold than the dose taken to induce the therapeutic effect of the drug. Generally, a drug or other therapeutic agent with a narrow therapeutic range (i.e. having little difference between toxic and therapeutic doses) may have its dosage adjusted according to measurements of its blood levels in the person taking it. This may be achieved through therapeutic drug monitoring (TDM) protocols. TDM is recommended for use in the treatment of psychiatric disorders with lithium due to its narrow therapeutic range.
Types Based on efficacy and safety of drugs, there are two types of therapeutic index:
Safety-based therapeutic index
T I safety = L D 50 E D 50 {\displaystyle TI_{\text{safety}}={\frac {LD_{50}}{ED_{50}}}}
It is desirous for the value of LD50 to be as large as possible, to decrease risk of lethal effects and increase the therapeutic window. In the above formula, TIsafety increases as the difference between LD50 and ED50 increases—hence, a higher safety-based therapeutic index indicates a larger therapeutic window, and vice versa.
Efficacy-based therapeutic index In pharmacology, potency (e.g. ED50) and efficacy (maximal effect, Emax) are distinct properties of drug action. The therapeutic index is typically defined using dose-based measures (such as TD50/ED50) and does not incorporate efficacy directly. The use of terms such as "efficacy-based therapeutic index" is uncommon in standard pharmacology texts and may reflect a conflation of efficacy with dose-based safety margins.
T I efficacy = E D 50 T D 50 {\displaystyle TI_{\text{efficacy}}={\frac {ED_{50}}{TD_{50}}}}
Ideally the ED50 is as low as possible for faster drug response and larger therapeutic window, whereas a drugs TD50 is ideally as large as possible to decrease risk of toxic effects. In the above equation, the greater the difference between ED50 and TD50, the smaller the value of TIefficacy. Hence, a lower efficacy-based therapeutic index indicates a larger therapeutic window.
Protective index Similar to safety-based therapeutic index, the protective index uses TD50 (median toxic dose) in place of LD50.
Protective index = T D 50 E D 50 = 1 T I efficacy {\displaystyle {\text{Protective index}}={\frac {TD_{50}}{ED_{50}}}={\frac {1}{TI_{\text{efficacy}}}}}
For many substances, toxicity can occur at levels far below lethal effects (that cause death), and thus, if toxicity is properly specified, the protective index is often more informative about a substance's relative safety. Nevertheless, the safety-based therapeutic index ( T I safety {\displaystyle {TI_{\text{safety}}}} ) is still useful as it can be considered an upper bound of the protective index, and the former also has the advantages of objectivity and easier comprehension. Since the protective index (PI) is calculated as TD50 divided by ED50, it can be mathematically expressed that:
T I efficacy = 1 Protective index {\displaystyle TI_{\text{efficacy}}={\frac {1}{\text{Protective index}}}}
… excerpt ends here. Continue reading the full article.
